FOXO3 and diabetic neuropathy: Deacetylation of FOXO3a by SIRT1 decreased oxidative stress in the N2A cells and helped to alleviate mitochondrial dysfunction, which helped to manage diabetic neuropathy, according to another study performed on STZ-induced diabetic mice [101].